.Pharmacolibrary.Drugs.ATC.J.J01MA14 .Pharmacolibrary.Drugs.ATC.J.J01MA14| name: | Moxifloxacin |
| ATC code: | J01MA14 | route: | oral |
| n-compartments | 2 |
Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic used to treat various bacterial infections, including respiratory tract infections, skin and soft tissue infections, and intra-abdominal infections. It is approved for use in many countries and commonly administered orally or intravenously.
Pharmacokinetic parameters observed in healthy adult volunteers after single-dose oral administration.
Greenberg, RG, et al., & Walter, EB (2022). Population Pharmacokinetics of Moxifloxacin in Children. Paediatric drugs 24(2) 163–173. DOI:10.1007/s40272-022-00493-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35284983
Radtke, KK, et al., & Garcia-Prats, AJ (2022). Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(8) 1372–1381. DOI:10.1093/cid/ciab641 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34286843
Bock, M, et al., & Moser, C (2023). Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 77(2) 242–251. DOI:10.1093/cid/ciad168 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36947131